Difference between revisions of "Pegfilgrastim (Neulasta)"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
m
Line 13: Line 13:
  
 
==Also known as==
 
==Also known as==
pegylated GCSF, G-CSF, or granulocyte colony stimulating factor.
+
*'''Generic names:''' pegylated GCSF, pegylated G-CSF, pegylated granulocyte colony stimulating factor
 +
*'''Brand name:''' Neulasta
  
 
==References==
 
==References==
Line 19: Line 20:
  
 
[[Category:Drug index]]
 
[[Category:Drug index]]
[[Category:Hematopoietic growth factors]]
+
[[Category:Subcutaneous medications]]
[[Category:Granulocyte growth factors]]
+
[[Category:Pegylated medications]]
 +
[[Category:Granulocyte colony-stimulating factors]]
  
 
[[Category:Drugs FDA approved in 2002]]
 
[[Category:Drugs FDA approved in 2002]]

Revision as of 03:44, 17 November 2017

General information

Class/mechanism: Recombinant human granulocyte colony-stimulating factor (G-CSF). Binds to cell surface receptors on hematopoietic cells and stimulates proliferation‚ differentiation, and some end-cell functional activation. The Neulasta formulation involves Filgrastim (Neupogen) being covalently conjugated to monomethoxypolyethylene glycol (mPEG), increasing its half-life.[1][2][3]
Route: SC
Extravasation: n/a

  • "Do not administer Neulasta between 14 days before and 24 hours after administration of cytotoxic chemotherapy."[1]

For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.[1]

Patient drug information

Also known as

  • Generic names: pegylated GCSF, pegylated G-CSF, pegylated granulocyte colony stimulating factor
  • Brand name: Neulasta

References